CASSIPA FDA approval date

The FDA approved CASSIPA on 7 Sep 2018.

FDA approval date
7 Sep 2018

Drug identity has not yet been verified against registry records

Also recorded as BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2018-09-07DayCASSIPAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA208042", "applicant_as_listed_by_fda": "TEVA PHARMS USA", "brand_names": ["CASSIPA"], "active_ingredients": ["BUPRENORPHINE HYDROCHLORIDE", "NALOXONE HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20180907", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026